Grufity logo
Grufity logo
CELZ

CELZ - Creative Medical Technology Holdings Stock Price, Fair Value and News

$2.22-0.17 (-7.11%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

35/100

CELZ

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

35/100

CELZ

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

CELZ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CELZ Price Action

Last 7 days

8.3%

Last 30 days

4.9%

Last 90 days

25%

Trailing 12 Months

7.8%

CELZ RSI Chart

CELZ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CELZ Valuation

Market Cap

8.2M

Price/Earnings (Trailing)

-1.42

Price/Sales (Trailing)

1.4K

EV/EBITDA

-0.43

Price/Free Cashflow

-1.47

CELZ Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

CELZ Fundamentals

CELZ Revenue

Rev. Growth (Yr)

-5.44%

Rev. Growth (Qtr)

56.63%

CELZ Earnings

Earnings (TTM)

-5.8M

Earnings Growth (Yr)

14.23%

Earnings Growth (Qtr)

25.57%

CELZ Profitability

Operating Margin

83.43%

EBT Margin

-96010.47%

Return on Equity

-93.95%

Return on Assets

-89.46%

Free Cashflow Yield

-68.09%

CELZ Investor Care

Shares Dilution (1Y)

43.25%

Diluted EPS (TTM)

-2.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2026----
202514.0K6.0K6.0K6.0K
2024-35.6K17.0K14.0K
2023--79.6K82.6K
2022102.8K92.8K137.8K88.6K
2021-132.4K114.5K105.3K
2020165.3K165.0K164.8K164.5K
2019165.6K222.4K227.5K165.5K
201834.7K64.6K94.5K124.4K
2017---4.8K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Creative Medical Technology Holdings

CELZ
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
 CEO
 WEBSITEcreativemedicaltechnology.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES4

Creative Medical Technology Holdings Frequently Asked Questions

CELZ is the stock ticker symbol of Creative Medical Technology Holdings. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Creative Medical Technology Holdings is 8.84 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, CELZ's PE ratio (Price to Earnings) is -1.53 and Price to Sales (PS) ratio is 1.47 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CELZ PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Creative Medical Technology Holdings has provided -0.69 (multiply by 100 for percentage) rate of return.